Skip to navigation menu Skip to content
Clinical Trial Search block Test

A PHASE 3 STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF REVACCINATING PREGNANT PARTICIPANTS DURING SUBSEQUENT PREGNANCIES AND PERSISTENCE OF IMMUNITY OF A SINGLE DOSE OF A BIVALENT RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE

Marguerite_RSV_C3671059

What is the goal of the study?

This is a phase 3 study of revaccination in subsequent pregnancies with RSV Vaccine evaluating the duration of protection of a single dose.

Who can participate in the study?

Everyone

Study Team: